Background. Rates of mastectomy with immediate reconstruction are rising. Skin flap necrosis after this procedure is a recognized complication that can have an impact on cosmetic outcomes and patient satisfaction, and in worst cases can potentially delay adjuvant therapies. Many retrospective studies of this complication have identified variable event rates and inconsistent associated factors. Methods. A prospective study was designed to capture the rate of skin flap necrosis as well as pre-, intra-, and postoperative variables, with follow-up assessment to 8 weeks postoperatively. Uni-and multivariate analyses were performed for factors associated with skin flap necrosis. Results. Of 606 consecutive procedures, 85 (14 %) had some level of skin flap necrosis: 46 mild (8 %), 6 moderate (1 %), 31 severe (5 %), and 2 uncategorized (0.3 %). Univariate analysis for any necrosis showed smoking, history of breast augmentation, nipple-sparing mastectomy, and time from incision to specimen removal to be significant. In multivariate models, nipple-sparing, time from incision to specimen removal, sharp dissection, and previous breast reduction were significant for any necrosis.
Univariate analysis of only moderate or severe necrosis showed body mass index, diabetes, nipple-sparing mastectomy, specimen size, and expander size to be significant. Multivariate analysis showed nipple-sparing mastectomy and specimen size to be significant. Nipple-sparing mastectomy was associated with higher rates of necrosis at every level of severity. Conclusions. Rates of skin flap necrosis are likely higher than reported in retrospective series. Modifiable technical variables have limited the impact on rates of necrosis.
Patients with multiple risk factors should be counseled about the risks, especially if they are contemplating nipplesparing mastectomy.
Mastectomy is a common procedure chosen increasingly by patients for breast cancer management. Currently, nearly 40 % of women in the United States with breast cancer undergo mastectomy each year, and increasing numbers are opting for immediate reconstruction, 1,2 generating great clinical interest in the potential complications of the procedure.
The most recent national data indicate that the choice of procedure is becoming dichotomized, with women choosing either bilateral mastectomies or breast conservation. [1] [2] [3] [4] [5] In contrast to lumpectomy, an outpatient surgical procedure with very low complication rates, mastectomy with reconstruction generally requires an overnight stay and has higher complication rates. Wound complications, including flap necrosis, are the most common complications and may have a significant impact on both cosmetic outcomes and costs. Severe flap necrosis may delay adjuvant chemotherapy or radiotherapy.
Additionally, an increasing number of women undergoing mastectomy with reconstruction are opting for nipple-sparing procedures. Ischemia of the nipple and areola are common with this procedure, and flap necrosis of this area and the surrounding skin are recognized complications. 6, 7 As surgical practice and patient choice continue to evolve, it is important to define the risks of potential complications to improve patient selection and counseling during the decision-making process.
The reported rates of skin flap necrosis range from 2 to 22 % in retrospective studies. 1, [8] [9] [10] [11] [12] [13] [14] [15] The literature is inconsistent due to differing definitions of skin flap necrosis and variable patient selection criteria. Studies have shown many factors to be associated with skin flap necrosis, including smoking, 9, 13, 14, 16 obesity, 1, 8, 9, 12, 14, 15, [17] [18] [19] 17, 18 and larger breasts. 8, 23 To address the limitations in the literature, we designed a prospective study to determine the rate of skin flap necrosis after mastectomy with reconstruction and to identify potentially modifiable factors that could improve patient selection and outcomes.
METHODS
With approval from the Institutional Review Board, the Breast Surgery Service and the Plastic and Reconstructive Surgery Service at Memorial Sloan Kettering Cancer Center developed a list of potentially important patientand surgeon-level study variables. Pre-, intra-, and postoperative data with follow-up assessment to 8 weeks postoperatively were collected prospectively on all patients undergoing uni-or bilateral mastectomy and reconstruction from 10 September 2013 to 28 February 2014.
The study had no exclusion criteria and included patients with prior cancer treatment, neoadjuvant chemotherapy, skin-sparing or nipple-sparing mastectomy, and tissue expander, implant, or autologous tissue reconstruction. All surgeons from both services participated.
Intraoperative pre-incision measurements of flap dimensions were performed as diagrammed in Fig. 1 . At completion of the mastectomy, the plastic surgery team determined whether more than 5 cm of dermis was exposed on the mastectomy flaps. The plastic surgery team also trimmed the skin flaps intraoperatively to facilitate wound closure or to address vascular compromise noted at visual inspection. The indication for trimming was not captured. Indocyanine green imaging was not used in this study.
Skin flap necrosis was defined as mild (no intervention needed, healing complete at 8 weeks), moderate (office debridement, healing complete at 8 weeks), or severe (OR debridement, implant loss, or healing not complete at 8 weeks).
All analyses were performed per breast, not per patient. Patient characteristics were summarized using frequency and percentage for categorical variables, and median and range for continuous variables. Factors associated with any necrosis and moderate or severe necrosis were identified using univariate logistic regression models, with oncologic surgeon and reconstructive surgeon random effects to account for possible correlation between outcomes from the same surgeon. Factors with a p value lower than 0.1 on univariate analysis were candidates for inclusion in the multivariate models, and backward selection until all variables had p values lower than 0.1 was used to create the final models. Because expander size was defined only in the subgroup with implant/tissue expander reconstruction and width of the skin ellipse was defined only for patients with skin-sparing mastectomy, separate models were built on these subgroups to allow these variables. All statistical analyses were performed using SAS 9.2 (SAS Institute, Cary, NC, USA). Two-sided p values lower than 0.05 were considered significant.
RESULTS
During the study period, 606 mastectomies were performed for 376 patients (unilateral mastectomies for 146 patients and bilateral mastectomies for 230 patients). Of the 606 procedures, 279 (46 %) were for invasive cancer, 69 (11 %) were for DCIS, 1 (0.2 %) was for malignant phyllodes tumor, and 257 (42 %) were risk-reducing mastectomies. 24 The median patient age was 48 years (range 22-76 years), and the median body mass index (BMI) was 25 Table 1 .
The study included 511 skin-sparing mastectomies (84 %) and 95 nipple-sparing mastectomies (16 %). Tissue expander or implant reconstruction accounted for 567 (94 %) of the reconstructive procedures, and the remaining 39 (6 %) were autologous tissue reconstruction procedures [10 transverse rectus abdominis myocutaneous (TRAM) flaps, 24 deep inferior epigastric perforators (DIEP), 5 latissimus dorsi]. The acellular dermal matrix was used in 48 (8.5 %) of the expander/implant cases. Of the 230 bilateral procedures (460 breasts), 131 (33 % of breasts, data missing for 65 breasts) were performed by two teams of breast surgeons (i.e., a fellow and an attending surgeon and two assistants for the case). The participants in the study were 12 breast surgeons and 6 plastic surgeons.
Any Skin Flap Necrosis
Overall, 85 (14 %) breasts in 67 patients had some degree of skin flap necrosis: 46 mild (8 %), 6 moderate (1 %), and 31 severe (5 %). Two patients (0.3 %) with skin flap necrosis were not categorized because they received follow-up assessment at other institutions. The median size of the necrotic tissue, reported as the largest single dimension, was 3 cm (range 0-24 cm), 9 cm (range 1.5-15 cm), and 8 cm (range 0.5-26 cm), respectively. Of the severe necrosis breasts, 25 were categorized as such because they were not healed by 8 weeks postoperatively. Debridement was performed for nine breasts in the operating room, and four implants were lost (Table 2 ). Smoking (current or in the last 6 months) (p = 0.05), history of breast augmentation (p \ 0.01), nipple-sparing mastectomy (p \ 0.01), and time from incision to specimen removal (p \ 0.01) were significantly associated with any degree of necrosis by univariate logistic regression analysis. Previous breast reduction, diabetes, sharp dissection, and expander size were not statistically significant, but had p values lower than 0.1 and were included in the multivariate models.
Two multivariate models were built. One excluded the expander/implant size variable to allow inclusion of all patients regardless of reconstruction type. A second model included the expander/implant size variable and included only patients undergoing tissue expander or implant reconstruction. In the first model, nipple-sparing (p \ 0.01), time from incision to specimen removal (p \ 0.01), sharp dissection (p \ 0.01), and smoking (p = 0.03) were significantly associated with any degree of necrosis (results not shown). In the second model, these factors remained significantly associated with any degree of necrosis, except smoking (p = 0.08), and previous breast reduction (p \ 0.01) also was associated with necrosis (Table 3) . No significant differences in rates of necrosis were found History of RT 44 (7) Prior breast biopsy/lumpectomy 138 ( between the oncologic and plastic surgeons in either analysis.
Moderate or Severe Necrosis
In the univariate analysis of factors associated with moderate or severe necrosis, BMI (p \ 0.01), diabetes (p \ 0.01), nipple-sparing mastectomy (p \ 0.01), specimen size (p = 0.03), and expander size (p = 0.02) were significant. The width of the skin ellipse was not significant but had a p value lower than 0.1 and was included in the multivariable models.
We first built a multivariate model on the subset of patients who had skin-sparing mastectomy and tissue expander/implant reconstruction that included the expander/ implant size and width of skin ellipse variables. Both of these variables were eventually dropped out of the model, allowing inclusion of all procedures in the final model. In the final model, only nipple-sparing mastectomy (p \ 0.01) and specimen size (p \ 0.01) were significantly associated with moderate or severe necrosis (Table 4) . No significant differences were found between the oncologic and plastic surgeons in rates of moderate or severe necrosis. Nipplesparing mastectomy was associated with significantly more skin flap necrosis at all levels of severity (p \ 0.01) (Fig. 2) .
DISCUSSION
During the study period, the overall rate of skin flap necrosis after mastectomy with reconstruction was 14 %. This is higher than in many published retrospective reports 11 but represents a more accurate estimate because prospective data collection allowed us to identify mild necrosis, which by our definition does not require debridement or a return to the operating room and is unlikely to be well documented in the medical record. We chose to define the degree of necrosis in easily reproducible terms and found that the majority of necrosis was mild, did not delay adjuvant therapy, and likely had little impact on the patient's experience, although we did not specifically measure this.
Moderate and severe necroses had a much larger impact on patient outcomes and were much less common. Returns to the operating room and implant loss were rare, with each occuring for less than 2 % of patients. This is lower than the previously reported rates of 2.7 and 2.5 % from our institution. 10 These studies looked at reconstructive failure out to 6 months after surgery, which likely accounts for the difference. We specifically did not limit our definition of severe necrosis to these events, however, because delayed wound healing without the need for return to the operating room also can have a significant impact on outcomes. If a patient is not healed by 8 weeks postoperatively, this indicates a more severe degree of ischemia or woundhealing problems, which may be associated with infection, increases the risk of dehiscence, and can potentially delay the receipt of adjuvant therapy.
Although we had very few implants lost, the patients with lost implants warrant special interest because prior studies have shown that patients who lose their implant have a high rate of foregoing any further reconstruction. 25 The low implant loss rate in our study may have been due, in part, to our practice of full muscle coverage whenever possible for tissue expander-based reconstuction.
Smoking status is the most consistent patient factor to be associated with skin flap necrosis after mastectomy with reconstruction, more than doubling the risk for necrosis in prior studies. 13, 14, 16 Our multivariate analysis did not show this factor to be significantly associated with any skin flap necrosis or moderate to severe necrosis. This may have been due to our definition of current or past smoking status, which included those who had quit in the last 6 months.
Prior breast-reduction surgery also was significantly associated with any necrosis in our study. This variable has not been examined in prior studies, limiting comparisons. The presence of prior incisions on the breast likely results in more ischemia in the dissected flaps, thereby contributing to necrosis.
Previous studies have shown breast size measured by cup size 23 and BMI 17, 19, 26 to be associated with skin flap necrosis. We measured these variables as well as specimen size, and all clearly were highly correlated. Multivariable analysis showed only specimen size to be associated with 31 (5) moderate to severe necrosis, suggesting that it represents a more specific identification of the reason why cup size and BMI have been significant factors in the past. Although technical variables had limited impact in our study, a few merit discussion. Prior studies have shown tumescence to be associated with skin flap necrosis, 16, 17 but this was not a significant factor in our study, consistent with a study by Khavanin et al. 26 in 2014. These varying results could be a signal of surgeon or institution variability.
In our study, sharp dissection (knife vs. cautery) was associated with any necrosis but not moderate to severe necrosis, and this has not been previously identified as a risk factor. Time to specimen removal also was a significant risk factor for any necrosis but not for moderate to severe necrosis. This variable too has not been identified in prior studies and likely is related to specimen size and surgeon experience. All of the attending surgeons in this study were breast specialists, but their time in practice ranged from 1 year to more than 20 years, and trainees did participate in the majority of cases. The level of participation varied, and we were not able to capture this variability in our data. The rates may be even higher in centers with less experienced surgeons.
Nipple-sparing mastectomy was the most significant predictor of skin flap necrosis and has been associated with higher complication rates in multiple studies. 11, 23, 27 Our study confirmed that patients choosing this procedure have a significant risk not only for necrosis of the nipple areolar complex but also for skin flap necrosis. Although this may not deter patients from this choice, it does warrant a more extensive conversation to ensure that the patients understand the potential outcomes.
Studies of other modifiable variables that may decrease complications for this procedure, such as the incision 11, 23, 27 are inconsistent. Although the long-term oncologic outcomes for nipple-sparing mastectomy still are not well established, it is clear that the acute complication rates are significantly higher than the complication rates for skin-sparing mastectomy. This may be offset by the overall higher satisfaction of these patients with the outcomes. 28, 29 The level of satisfaction, however, is affected by the occurrence of postoperative complications, including skin flap necrosis, again warranting a frank discussion with patients who choose this procedure. These patients may benefit from nipple-areola delay procedures aiming to improve the blood supply of the nipple-areola complex, an approach that merits further investigation.
Identification of patients undergoing nipple-sparing mastectomy with the highest risk of ischemic complications could be useful. A study from Stanford used intraoperative skin perfusion assessment that applied laserassisted indocyanine green angiography (SPY Elite) before mastectomy to identify patterns of perfusion associated with ischemic complications of the nipple-areolar complex. 30 This technique also has been applied to skin-sparing mastectomy and was found to correlate well with patient outcomes. 31 Although this method may help to identify patients at higher risk for necrosis, it is not cost effective if applied broadly, 32 and we did not use this method in our study. Even with optimal patient selection, the SPY information may not be clinically useful because most surgeons are hesitant to default to primary removal of the nipple-areolar complex even when the SPY results indicate extremely poor perfusion.
Although we collected data on a large number of procedures, some variables were underrepresented. Prior radiation therapy has been studied as a risk factor for skin and wound complications after mastectomy 9, 17, 19, 33, 34 and Factors with p B 0.1 on UVA were candidates for MVA; backward selection was used to determine final factors included in MVA. N = 518 for MVA a Excluded by backward selection OR odds ratio, CI confidence interval, BMI body mass index, RT radiation therapy was underrepresented in our study population, with only 7 % of patients having prior radiation. We also had no specific data on traction injury, although flap length, incision size, and time to specimen removal may be surrogates of this. In addition, there likely are other modes of injury that contribute to flap necrosis. Although the rates of skin flap necrosis do vary somewhat by institution and individual, this study provides evidence that the rates of any necrosis are likely higher than reported in many restrospective series. Although modifiable technical variables had little impact on rates of clinically significant skin flap necrosis, patients with multiple minor risk factors may be targeted for counseling regarding this risk, especially if they are contemplating nipple-sparing mastectomy. Discussion of the potential for wound-healing complications is especially important for patients electing risk-reducing mastectomy. Studies to evaluate interventions to decrease the incidence of flap necrosis among high-risk patients are warranted. 
